XML 51 R32.htm IDEA: XBRL DOCUMENT
v3.23.2

Fair Value (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Fair Value Disclosures [Abstract] |
Assets and Liabilities Measured at Fair Value on Recurring Basis | The following represents the hierarchy for our assets and liabilities measured at fair value on a recurring basis:
| June 30, 2023 |
(In millions) | Total |  | NAV |  | Level 1 |  | Level 2 |  | Level 3 |
Assets |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |
US government and agencies | $ | 4,821 |  |  | $ | — |  |  | $ | 4,814 |  |  | $ | 7 |  |  | $ | — |  |
US state, municipal and political subdivisions | 1,054 |  |  | — |  |  | — |  |  | 1,054 |  |  | — |  |
Foreign governments | 1,008 |  |  | — |  |  | — |  |  | 960 |  |  | 48 |  |
Corporate | 67,410 |  |  | — |  |  | 10 |  |  | 64,940 |  |  | 2,460 |  |
CLO | 18,521 |  |  | — |  |  | — |  |  | 18,521 |  |  | — |  |
ABS | 11,350 |  |  | — |  |  | — |  |  | 6,045 |  |  | 5,305 |  |
CMBS | 4,500 |  |  | — |  |  | — |  |  | 4,488 |  |  | 12 |  |
RMBS | 6,488 |  |  | — |  |  | — |  |  | 6,482 |  |  | 6 |  |
Total AFS securities | 115,152 |  |  | — |  |  | 4,824 |  |  | 102,497 |  |  | 7,831 |  |
Trading securities | 1,628 |  |  | — |  |  | 24 |  |  | 1,566 |  |  | 38 |  |
Equity securities | 896 |  |  | — |  |  | 194 |  |  | 635 |  |  | 67 |  |
Mortgage loans | 34,668 |  |  | — |  |  | — |  |  | — |  |  | 34,668 |  |
Funds withheld at interest – embedded derivative | (4,356) |  |  | — |  |  | — |  |  | — |  |  | (4,356) |  |
Derivative assets | 5,114 |  |  | — |  |  | 111 |  |  | 5,003 |  |  | — |  |
Short-term investments | 650 |  |  | — |  |  | — |  |  | 620 |  |  | 30 |  |
Other investments | 547 |  |  | — |  |  | — |  |  | 210 |  |  | 337 |  |
Cash and cash equivalents | 10,601 |  |  | — |  |  | 10,601 |  |  | — |  |  | — |  |
Restricted cash | 2,203 |  |  | — |  |  | 2,203 |  |  | — |  |  | — |  |
Investments in related parties |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |
Corporate | 1,343 |  |  | — |  |  | — |  |  | 172 |  |  | 1,171 |  |
CLO | 3,806 |  |  | — |  |  | — |  |  | 3,311 |  |  | 495 |  |
ABS | 8,258 |  |  | — |  |  | — |  |  | 516 |  |  | 7,742 |  |
Total AFS securities – related parties | 13,407 |  |  | — |  |  | — |  |  | 3,999 |  |  | 9,408 |  |
Trading securities | 867 |  |  | — |  |  | — |  |  | — |  |  | 867 |  |
Equity securities | 313 |  |  | — |  |  | 61 |  |  | — |  |  | 252 |  |
Mortgage loans | 1,296 |  |  | — |  |  | — |  |  | — |  |  | 1,296 |  |
Investment funds | 1,061 |  |  | — |  |  | — |  |  | — |  |  | 1,061 |  |
Funds withheld at interest – embedded derivative | (1,297) |  |  | — |  |  | — |  |  | — |  |  | (1,297) |  |
Other investments | 343 |  |  | — |  |  | — |  |  | — |  |  | 343 |  |
Reinsurance recoverable | 1,436 |  |  | — |  |  | — |  |  | — |  |  | 1,436 |  |
Other assets | 433 |  |  | — |  |  | — |  |  | — |  |  | 433 |  |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |
Trading securities | 1,720 |  |  | — |  |  | — |  |  | 295 |  |  | 1,425 |  |
Mortgage loans | 2,113 |  |  | — |  |  | — |  |  | — |  |  | 2,113 |  |
Investment funds | 14,109 |  |  | 12,758 |  |  | — |  |  | — |  |  | 1,351 |  |
Other investments | 100 |  |  | — |  |  | — |  |  | 1 |  |  | 99 |  |
Cash and cash equivalents | 122 |  |  | — |  |  | 122 |  |  | — |  |  | — |  |
Total assets measured at fair value | $ | 203,126 |  |  | $ | 12,758 |  |  | $ | 18,140 |  |  | $ | 114,826 |  |  | $ | 57,402 |  |
Liabilities |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities |  |  |  |  |  |  |  |  |  |
Embedded derivative | $ | 8,198 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 8,198 |  |
Universal life benefits | 854 |  |  | — |  |  | — |  |  | — |  |  | 854 |  |
Future policy benefits |  |  |  |  |  |  |  |  |  |
AmerUs Life Insurance Company (AmerUs) Closed Block | 1,159 |  |  | — |  |  | — |  |  | — |  |  | 1,159 |  |
Indianapolis Life Insurance Company (ILICO) Closed Block and life benefits | 571 |  |  | — |  |  | — |  |  | — |  |  | 571 |  |
Market risk benefits | 3,195 |  |  | — |  |  | — |  |  | — |  |  | 3,195 |  |
Derivative liabilities | 1,753 |  |  | — |  |  | 35 |  |  | 1,717 |  |  | 1 |  |
Other liabilities | 181 |  |  | — |  |  | — |  |  | (28) |  |  | 209 |  |
Total liabilities measured at fair value | $ | 15,911 |  |  | $ | — |  |  | $ | 35 |  |  | $ | 1,689 |  |  | $ | 14,187 |  |
| December 31, 2022
(In millions) | Total |  | NAV |  | Level 1 |  | Level 2 |  | Level 3
Assets |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |
US government and agencies | $ | 2,577 |  |  | $ | — |  |  | $ | 2,570 |  |  | $ | 7 |  |  | $ | — |
US state, municipal and political subdivisions | 927 |  |  | — |  |  | — |  |  | 927 |  |  | — |
Foreign governments | 907 |  |  | — |  |  | — |  |  | 906 |  |  | 1 |
Corporate | 60,901 |  |  | — |  |  | — |  |  | 59,236 |  |  | 1,665 |
CLO | 16,493 |  |  | — |  |  | — |  |  | 16,493 |  |  | — |
ABS | 10,527 |  |  | — |  |  | — |  |  | 5,660 |  |  | 4,867 |
CMBS | 4,158 |  |  | — |  |  | — |  |  | 4,158 |  |  | — |
RMBS | 5,914 |  |  | — |  |  | — |  |  | 5,682 |  |  | 232 |
Total AFS securities | 102,404 |  |  | — |  |  | 2,570 |  |  | 93,069 |  |  | 6,765 |
Trading securities | 1,595 |  |  | — |  |  | 23 |  |  | 1,519 |  |  | 53 |
Equity securities | 1,087 |  |  | — |  |  | 150 |  |  | 845 |  |  | 92 |
Mortgage loans | 27,454 |  |  | — |  |  | — |  |  | — |  |  | 27,454 |
Funds withheld at interest – embedded derivative | (4,847) |  |  | — |  |  | — |  |  | — |  |  | (4,847) |
Derivative assets | 3,309 |  |  | — |  |  | 42 |  |  | 3,267 |  |  | — |
Short-term investments | 520 |  |  | — |  |  | 29 |  |  | 455 |  |  | 36 |
Other investments | 611 |  |  | — |  |  | — |  |  | 170 |  |  | 441 |
Cash and cash equivalents | 7,779 |  |  | — |  |  | 7,779 |  |  | — |  |  | — |
Restricted cash | 628 |  |  | — |  |  | 628 |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |
Corporate | 982 |  |  | — |  |  | — |  |  | 170 |  |  | 812 |
CLO | 3,079 |  |  | — |  |  | — |  |  | 2,776 |  |  | 303 |
ABS | 5,760 |  |  | — |  |  | — |  |  | 218 |  |  | 5,542 |
Total AFS securities – related parties | 9,821 |  |  | — |  |  | — |  |  | 3,164 |  |  | 6,657 |
Trading securities | 878 |  |  | — |  |  | — |  |  | — |  |  | 878 |
Equity securities | 279 |  |  | — |  |  | — |  |  | — |  |  | 279 |
Mortgage loans | 1,302 |  |  | — |  |  | — |  |  | — |  |  | 1,302 |
Investment funds | 959 |  |  | — |  |  | — |  |  | — |  |  | 959 |
Funds withheld at interest – embedded derivative | (1,425) |  |  | — |  |  | — |  |  | — |  |  | (1,425) |
Other investments | 303 |  |  | — |  |  | — |  |  | — |  |  | 303 |
Reinsurance recoverable | 1,388 |  |  | — |  |  | — |  |  | — |  |  | 1,388 |
Other assets | 481 |  |  | — |  |  | — |  |  | — |  |  | 481 |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |
Trading securities | 1,063 |  |  | — |  |  | 5 |  |  | 436 |  |  | 622 |
Mortgage loans | 2,055 |  |  | — |  |  | — |  |  | — |  |  | 2,055 |
Investment funds | 12,480 |  |  | 10,009 |  |  | — |  |  | — |  |  | 2,471 |
Other investments | 101 |  |  | — |  |  | — |  |  | 2 |  |  | 99 |
Cash and cash equivalents | 362 |  |  | — |  |  | 362 |  |  | — |  |  | — |
Total assets measured at fair value | $ | 170,587 |  |  | $ | 10,009 |  |  | $ | 11,588 |  |  | $ | 102,927 |  |  | $ | 46,063 |
Liabilities |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities |  |  |  |  |  |  |  |  |
Embedded derivative | $ | 5,841 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 5,841 |
Universal life benefits | 829 |  |  | — |  |  | — |  |  | — |  |  | 829 |
Future policy benefits |  |  |  |  |  |  |  |  |
AmerUs Closed Block | 1,164 |  |  | — |  |  | — |  |  | — |  |  | 1,164 |
ILICO Closed Block and life benefits | 548 |  |  | — |  |  | — |  |  | — |  |  | 548 |
Market risk benefits | 2,970 |  |  | — |  |  | — |  |  | — |  |  | 2,970 |
Derivative liabilities | 1,646 |  |  | — |  |  | 38 |  |  | 1,607 |  |  | 1 |
Other liabilities | 65 |  |  | — |  |  | — |  |  | (77) |  |  | 142 |
Total liabilities measured at fair value | $ | 13,063 |  |  | $ | — |  |  | $ | 38 |  |  | $ | 1,530 |  |  | $ | 11,495 |
Summary of Fair Value Option | The following represents the gains (losses) recorded for instruments for which we have elected the fair value option, including related parties and consolidated VIEs:
| Three months ended June 30, |  | Six months ended June 30,
(In millions) | 2023 |  | 2022 |  | 2023 |  | 2022
Trading securities | $ | (32) |  |  | $ | (161) |  |  | $ | 32 |  |  | $ | (368) |
Mortgage loans | (221) |  |  | (1,149) |  |  | 75 |  |  | (2,065) |
Investment funds | 27 |  |  | 36 |  |  | 91 |  |  | 56 |
Future policy benefits | 31 |  |  | 131 |  |  | 5 |  |  | 273 |
Other liabilities | (20) |  |  | — |  |  | (67) |  |  | — |
Total gains (losses) | $ | (215) |  |  | $ | (1,143) |  |  | $ | 136 |  |  | $ | (2,104) |
The following summarizes information for fair value option mortgage loans, including related parties and consolidated VIEs:
(In millions) | June 30, 2023 |  | December 31, 2022
Unpaid principal balance | $ | 41,122 |  |  | $ | 33,653 |
Mark to fair value | (3,045) |  |  | (2,842) |
Fair value | $ | 38,077 |  |  | $ | 30,811 |
The following represents our commercial mortgage loan portfolio 90 days or more past due and/or in non-accrual status:
(In millions) | June 30, 2023 |  | December 31, 2022
Unpaid principal balance of commercial mortgage loans 90 days or more past due and/or in non-accrual status | $ | 208 |  |  | $ | 74 |
Mark to fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status | (62) |  |  | (55) |
Fair value of commercial mortgage loans 90 days or more past due and/or in non-accrual status | $ | 146 |  |  | $ | 19 |
Fair value of commercial mortgage loans 90 days or more past due | $ | 21 |  |  | $ | 2 |
Fair value of commercial mortgage loans in non-accrual status | 125 |  |  | 19 |
The following represents our residential loan portfolio 90 days or more past due and/or in non-accrual status:
(In millions) | June 30, 2023 |  | December 31, 2022
Unpaid principal balance of residential mortgage loans 90 days or more past due and/or in non-accrual status | $ | 439 |  |  | $ | 522 |
Mark to fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status | (40) |  |  | (50) |
Fair value of residential mortgage loans 90 days or more past due and/or in non-accrual status | $ | 399 |  |  | $ | 472 |
Fair value of residential mortgage loans 90 days or more past due 1 | $ | 399 |  |  | $ | 472 |
Fair value of residential mortgage loans in non-accrual status | 239 |  |  | 360 |
1 As of June 30, 2023 and December 31, 2022 includes $160 million and $221 million, respectively, of residential mortgage loans that are guaranteed by US government-sponsored agencies.
The following is the estimated amount of gains (losses) included in earnings during the period attributable to changes in instrument-specific credit risk on our mortgage loan portfolio:
| Three months ended June 30, |  | Six months ended June 30,
(In millions) | 2023 |  | 2022 |  | 2023 |  | 2022
Mortgage loans | $ | (8) |  |  | $ | (34) |  |  | $ | (11) |  |  | $ | (52) |
Reconciliation of Level 3 Assets Measured on a Recurring Basis | The following are reconciliations for Level 3 assets and liabilities measured at fair value on a recurring basis. Transfers in and out of Level 3 are primarily based on changes in the availability of pricing sources, as described in the valuation methods above.
| Three months ended June 30, 2023
|  |  | Total realized and unrealized gains (losses) |  |  |  |  |  |  |  |  |  |
(In millions) | Beginning balance |  | Included in income |  | Included in OCI |  | Net purchases, issuances, sales and settlements |  | Net transfers in (out) |  | Ending balance |  | Total gains (losses) included in earnings 1 |  | Total gains (losses) included in OCI 1
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign governments | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | 47 |  |  | — |  |  | $ | 48 |  |  | $ | — |  |  | $ | — |
Corporate | 1,622 |  |  | — |  |  | 12 |  |  | 1,070 |  |  | (244) |  |  | 2,460 |  |  | — |  |  | 12 |
ABS | 4,942 |  |  | — |  |  | (31) |  |  | 894 |  |  | (500) |  |  | 5,305 |  |  | — |  |  | (30) |
CMBS | — |  |  | — |  |  | — |  |  | — |  |  | 12 |  |  | 12 |  |  | — |  |  | — |
RMBS | 238 |  |  | 3 |  |  | (1) |  |  | (3) |  |  | (231) |  |  | 6 |  |  | — |  |  | — |
Trading securities | 42 |  |  | 1 |  |  | — |  |  | (3) |  |  | (2) |  |  | 38 |  |  | — |  |  | — |
Equity securities | 71 |  |  | (4) |  |  | — |  |  | — |  |  | — |  |  | 67 |  |  | (4) |  |  | — |
Mortgage loans | 29,949 |  |  | (195) |  |  | — |  |  | 4,914 |  |  | — |  |  | 34,668 |  |  | (195) |  |  | — |
Funds withheld at interest – embedded derivative | (4,291) |  |  | (65) |  |  | — |  |  | — |  |  | — |  |  | (4,356) |  |  | — |  |  | — |
Short-term investments | 30 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 30 |  |  | — |  |  | — |
Other investments | 286 |  |  | (1) |  |  | — |  |  | 52 |  |  | — |  |  | 337 |  |  | (1) |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 959 |  |  | — |  |  | (1) |  |  | (2) |  |  | 215 |  |  | 1,171 |  |  | — |  |  | (1) |
CLO | 498 |  |  | — |  |  | (3) |  |  | — |  |  | — |  |  | 495 |  |  | — |  |  | (3) |
ABS | 7,005 |  |  | 5 |  |  | 5 |  |  | 443 |  |  | 284 |  |  | 7,742 |  |  | 1 |  |  | 2 |
Trading securities | 885 |  |  | (4) |  |  | — |  |  | (14) |  |  | — |  |  | 867 |  |  | (4) |  |  | — |
Equity securities | 251 |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | 252 |  |  | 1 |  |  | — |
Mortgage loans | 1,324 |  |  | (9) |  |  | — |  |  | (19) |  |  | — |  |  | 1,296 |  |  | (9) |  |  | — |
Investment funds | 1,034 |  |  | 27 |  |  | — |  |  | — |  |  | — |  |  | 1,061 |  |  | 27 |  |  | — |
Funds withheld at interest – embedded derivative | (1,266) |  |  | (31) |  |  | — |  |  | — |  |  | — |  |  | (1,297) |  |  | — |  |  | — |
Other investments | 338 |  |  | 5 |  |  | — |  |  | — |  |  | — |  |  | 343 |  |  | 5 |  |  | — |
Reinsurance recoverable | 1,470 |  |  | (34) |  |  | — |  |  | — |  |  | — |  |  | 1,436 |  |  | — |  |  | — |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | 648 |  |  | (4) |  |  | — |  |  | (8) |  |  | 789 |  |  | 1,425 |  |  | (4) |  |  | — |
Mortgage loans | 2,119 |  |  | (17) |  |  | — |  |  | 11 |  |  | — |  |  | 2,113 |  |  | (17) |  |  | — |
Investment funds | 2,581 |  |  | 5 |  |  | — |  |  | — |  |  | (1,235) |  |  | 1,351 |  |  | 6 |  |  | — |
Other investments | 97 |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | 99 |  |  | 2 |  |  | — |
Total Level 3 assets | $ | 50,833 |  |  | $ | (315) |  |  | $ | (19) |  |  | $ | 7,382 |  |  | $ | (912) |  |  | $ | 56,969 |  |  | $ | (192) |  |  | $ | (20) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Embedded derivative | $ | (6,747) |  |  | $ | (1,055) |  |  | $ | — |  |  | $ | (396) |  |  | $ | — |  |  | $ | (8,198) |  |  | $ | — |  |  | $ | — |
Universal life benefits | (879) |  |  | 25 |  |  | — |  |  | — |  |  | — |  |  | (854) |  |  | — |  |  | — |
Future policy benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AmerUs Closed Block | (1,190) |  |  | 31 |  |  | — |  |  | — |  |  | — |  |  | (1,159) |  |  | — |  |  | — |
ILICO Closed Block and life benefits | (579) |  |  | 8 |  |  | — |  |  | — |  |  | — |  |  | (571) |  |  | — |  |  | — |
Derivative liabilities | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |
Other liabilities | (189) |  |  | (20) |  |  | — |  |  | — |  |  | — |  |  | (209) |  |  | — |  |  | — |
Total Level 3 liabilities | $ | (9,585) |  |  | $ | (1,011) |  |  | $ | — |  |  | $ | (396) |  |  | $ | — |  |  | $ | (10,992) |  |  | $ | — |  |  | $ | — |
1 Related to instruments held at end of period.
| Three months ended June 30, 2022
|  |  | Total realized and unrealized gains (losses) |  |  |  |  |  |  |  |  |  |
(In millions) | Beginning balance |  | Included in income |  | Included in OCI |  | Net purchases, issuances, sales and settlements |  | Net transfers in (out) |  | Ending balance |  | Total gains (losses) included in earnings 1 |  | Total gains (losses) included in OCI 1
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign governments | $ | 2 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 2 |  |  | $ | — |  |  | $ | — |
Corporate | 1,499 |  |  | — |  |  | (58) |  |  | 40 |  |  | 107 |  |  | 1,588 |  |  | — |  |  | (58) |
CLO | 5 |  |  | — |  |  | (3) |  |  | (2) |  |  | — |  |  | — |  |  | — |  |  | — |
ABS | 3,783 |  |  | 2 |  |  | (65) |  |  | 148 |  |  | (274) |  |  | 3,594 |  |  | — |  |  | (66) |
CMBS | 10 |  |  | — |  |  | — |  |  | — |  |  | (10) |  |  | — |  |  | — |  |  | — |
RMBS | — |  |  | — |  |  | — |  |  | 68 |  |  | — |  |  | 68 |  |  | — |  |  | — |
Trading securities | 90 |  |  | (1) |  |  | — |  |  | 2 |  |  | (33) |  |  | 58 |  |  | — |  |  | — |
Equity securities | 438 |  |  | 8 |  |  | — |  |  | (3) |  |  | (381) |  |  | 62 |  |  | 8 |  |  | — |
Mortgage loans | 23,696 |  |  | (1,027) |  |  | — |  |  | 2,549 |  |  | — |  |  | 25,218 |  |  | (1,025) |  |  | — |
Investment funds | 19 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 19 |  |  | — |  |  | — |
Funds withheld at interest – embedded derivative | (1,882) |  |  | (2,076) |  |  | — |  |  | — |  |  | — |  |  | (3,958) |  |  | — |  |  | — |
Short-term investments | 59 |  |  | — |  |  | (1) |  |  | — |  |  | — |  |  | 58 |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 761 |  |  | — |  |  | (7) |  |  | 42 |  |  | 53 |  |  | 849 |  |  | — |  |  | (7) |
CLO | 332 |  |  | — |  |  | (7) |  |  | — |  |  | — |  |  | 325 |  |  | — |  |  | (7) |
ABS | 4,409 |  |  | 16 |  |  | (125) |  |  | (1,096) |  |  | 1,822 |  |  | 5,026 |  |  | — |  |  | (126) |
Trading securities | 252 |  |  | 4 |  |  | — |  |  | (808) |  |  | 1,443 |  |  | 891 |  |  | — |  |  | — |
Equity securities | 166 |  |  | (9) |  |  | — |  |  | (119) |  |  | 125 |  |  | 163 |  |  | — |  |  | — |
Mortgage loans | 1,456 |  |  | (72) |  |  | — |  |  | 32 |  |  | — |  |  | 1,416 |  |  | (73) |  |  | — |
Investment funds | 814 |  |  | 4 |  |  | — |  |  | — |  |  | — |  |  | 818 |  |  | 28 |  |  | — |
Funds withheld at interest – embedded derivative | (570) |  |  | (559) |  |  | — |  |  | — |  |  | — |  |  | (1,129) |  |  | — |  |  | — |
Short-term investments | 53 |  |  | — |  |  | — |  |  | — |  |  | (53) |  |  | — |  |  | — |  |  | — |
Reinsurance recoverable | 1,814 |  |  | (234) |  |  | — |  |  | — |  |  | — |  |  | 1,580 |  |  | — |  |  | — |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | — |  |  | — |  |  | — |  |  | — |  |  | 330 |  |  | 330 |  |  | — |  |  | — |
Mortgage loans | 1,880 |  |  | (50) |  |  | — |  |  | (2) |  |  | (202) |  |  | 1,626 |  |  | (50) |  |  | — |
Investment funds | 10,577 |  |  | 33 |  |  | — |  |  | (77) |  |  | (9,480) |  |  | 1,053 |  |  | 27 |  |  | — |
Other investments | 1,902 |  |  | — |  |  | — |  |  | 31 |  |  | (1,902) |  |  | 31 |  |  | — |  |  | — |
Total Level 3 assets | $ | 51,565 |  |  | $ | (3,961) |  |  | $ | (266) |  |  | $ | 805 |  |  | $ | (8,455) |  |  | $ | 39,688 |  |  | $ | (1,085) |  |  | $ | (264) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Embedded derivative | $ | (6,485) |  |  | $ | 1,519 |  |  | $ | — |  |  | $ | (210) |  |  | $ | — |  |  | $ | (5,176) |  |  | $ | — |  |  | $ | — |
Universal life benefits | (1,096) |  |  | 153 |  |  | — |  |  | — |  |  | — |  |  | (943) |  |  | — |  |  | — |
Future policy benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AmerUs Closed Block | (1,378) |  |  | 131 |  |  | — |  |  | — |  |  | — |  |  | (1,247) |  |  | — |  |  | — |
ILICO Closed Block and life benefits | (704) |  |  | 81 |  |  | — |  |  | — |  |  | — |  |  | (623) |  |  | — |  |  | — |
Derivative liabilities | (3) |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |
Total Level 3 liabilities | $ | (9,666) |  |  | $ | 1,886 |  |  | $ | — |  |  | $ | (210) |  |  | $ | — |  |  | $ | (7,990) |  |  | $ | — |  |  | $ | — |
1 Related to instruments held at end of period. |  |
| Six months ended June 30, 2023
|  |  | Total realized and unrealized gains (losses) |  |  |  |  |  |  |  |  |  |
(In millions) | Beginning balance |  | Included in income |  | Included in OCI |  | Net purchases, issuances, sales and settlements |  | Net transfers in (out) |  | Ending balance |  | Total gains (losses) included in earnings 1 |  | Total gains (losses) included in OCI 1
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign governments | $ | 1 |  |  | $ | — |  |  | $ | — |  |  | $ | 47 |  |  | $ | — |  |  | $ | 48 |  |  | $ | — |  |  | $ | — |
Corporate | 1,665 |  |  | (1) |  |  | 24 |  |  | 1,196 |  |  | (424) |  |  | 2,460 |  |  | — |  |  | 17 |
ABS | 4,867 |  |  | — |  |  | (50) |  |  | 1,049 |  |  | (561) |  |  | 5,305 |  |  | — |  |  | (46) |
CMBS | — |  |  | — |  |  | — |  |  | — |  |  | 12 |  |  | 12 |  |  | — |  |  | (1) |
RMBS | 232 |  |  | 6 |  |  | 2 |  |  | (3) |  |  | (231) |  |  | 6 |  |  | — |  |  | — |
Trading securities | 53 |  |  | 3 |  |  | — |  |  | (7) |  |  | (11) |  |  | 38 |  |  | 1 |  |  | — |
Equity securities | 92 |  |  | (12) |  |  | — |  |  | — |  |  | (13) |  |  | 67 |  |  | (12) |  |  | — |
Mortgage loans | 27,454 |  |  | 56 |  |  | — |  |  | 7,158 |  |  | — |  |  | 34,668 |  |  | 57 |  |  | — |
Funds withheld at interest – embedded derivative | (4,847) |  |  | 491 |  |  | — |  |  | — |  |  | — |  |  | (4,356) |  |  | — |  |  | — |
Short-term investments | 36 |  |  | — |  |  | (2) |  |  | (30) |  |  | 26 |  |  | 30 |  |  | — |  |  | — |
Other investments | 441 |  |  | — |  |  | — |  |  | (104) |  |  | — |  |  | 337 |  |  | (1) |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 812 |  |  | 1 |  |  | (8) |  |  | 151 |  |  | 215 |  |  | 1,171 |  |  | — |  |  | (8) |
CLO | 303 |  |  | — |  |  | 7 |  |  | 185 |  |  | — |  |  | 495 |  |  | — |  |  | 7 |
ABS | 5,542 |  |  | 9 |  |  | 49 |  |  | 1,858 |  |  | 284 |  |  | 7,742 |  |  | 4 |  |  | 46 |
Trading securities | 878 |  |  | 2 |  |  | — |  |  | (13) |  |  | — |  |  | 867 |  |  | (1) |  |  | — |
Equity securities | 279 |  |  | 5 |  |  | — |  |  | (32) |  |  | — |  |  | 252 |  |  | 5 |  |  | — |
Mortgage loans | 1,302 |  |  | 17 |  |  | — |  |  | (23) |  |  | — |  |  | 1,296 |  |  | 17 |  |  | — |
Investment funds | 959 |  |  | 70 |  |  | — |  |  | 32 |  |  | — |  |  | 1,061 |  |  | 70 |  |  | — |
Funds withheld at interest – embedded derivative | (1,425) |  |  | 128 |  |  | — |  |  | — |  |  | — |  |  | (1,297) |  |  | — |  |  | — |
Other investments | 303 |  |  | (2) |  |  | — |  |  | 42 |  |  | — |  |  | 343 |  |  | (2) |  |  | — |
Reinsurance recoverable | 1,388 |  |  | 48 |  |  | — |  |  | — |  |  | — |  |  | 1,436 |  |  | — |  |  | — |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | 622 |  |  | 8 |  |  | — |  |  | (10) |  |  | 805 |  |  | 1,425 |  |  | 8 |  |  | — |
Mortgage loans | 2,055 |  |  | 2 |  |  | — |  |  | 56 |  |  | — |  |  | 2,113 |  |  | 2 |  |  | — |
Investment funds | 2,471 |  |  | 23 |  |  | — |  |  | (8) |  |  | (1,135) |  |  | 1,351 |  |  | 23 |  |  | — |
Other investments | 99 |  |  | 2 |  |  | — |  |  | (2) |  |  | — |  |  | 99 |  |  | 2 |  |  | — |
Total Level 3 assets | $ | 45,582 |  |  | $ | 856 |  |  | $ | 22 |  |  | $ | 11,542 |  |  | $ | (1,033) |  |  | $ | 56,969 |  |  | $ | 173 |  |  | $ | 15 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Embedded derivative | $ | (5,841) |  |  | $ | (1,528) |  |  | $ | — |  |  | $ | (829) |  |  | $ | — |  |  | $ | (8,198) |  |  | $ | — |  |  | $ | — |
Universal life benefits | (829) |  |  | (25) |  |  | — |  |  | — |  |  | — |  |  | (854) |  |  | — |  |  | — |
Future policy benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AmerUs Closed Block | (1,164) |  |  | 5 |  |  | — |  |  | — |  |  | — |  |  | (1,159) |  |  | — |  |  | — |
ILICO Closed Block and life benefits | (548) |  |  | (23) |  |  | — |  |  | — |  |  | — |  |  | (571) |  |  | — |  |  | — |
Derivative liabilities | (1) |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |
Other liabilities | (142) |  |  | (67) |  |  | — |  |  | — |  |  | — |  |  | (209) |  |  | — |  |  | — |
Total Level 3 liabilities | $ | (8,525) |  |  | $ | (1,638) |  |  | $ | — |  |  | $ | (829) |  |  | $ | — |  |  | $ | (10,992) |  |  | $ | — |  |  | $ | — |
1 Related to instruments held at end of period.
| Six months ended June 30, 2022
|  |  | Total realized and unrealized gains (losses) |  |  |  |  |  |  |  |  |  |
(In millions) | January 1, 2022 |  | Included in income |  | Included in OCI |  | Net purchases, issuances, sales and settlements |  | Net transfers in (out) |  | Ending balance |  | Total gains (losses) included in earnings 1 |  | Total gains (losses) included in OCI 1
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign governments | $ | 2 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 2 |  |  | $ | — |  |  | $ | — |
Corporate | 1,339 |  |  | (3) |  |  | (77) |  |  | 180 |  |  | 149 |  |  | 1,588 |  |  | — |  |  | (76) |
CLO | 14 |  |  | (2) |  |  | — |  |  | (12) |  |  | — |  |  | — |  |  | — |  |  | — |
ABS | 3,619 |  |  | 7 |  |  | (95) |  |  | — |  |  | 63 |  |  | 3,594 |  |  | — |  |  | (89) |
CMBS | 43 |  |  | — |  |  | (17) |  |  | — |  |  | (26) |  |  | — |  |  | — |  |  | 1 |
RMBS | — |  |  | — |  |  | — |  |  | 68 |  |  | — |  |  | 68 |  |  | — |  |  | — |
Trading securities | 69 |  |  | (6) |  |  | — |  |  | 8 |  |  | (13) |  |  | 58 |  |  | — |  |  | — |
Equity securities | 429 |  |  | 17 |  |  | — |  |  | (3) |  |  | (381) |  |  | 62 |  |  | 16 |  |  | — |
Mortgage loans | 21,154 |  |  | (1,771) |  |  | — |  |  | 5,835 |  |  | — |  |  | 25,218 |  |  | (1,767) |  |  | — |
Investment funds | 18 |  |  | 1 |  |  | — |  |  | — |  |  | — |  |  | 19 |  |  | 1 |  |  | — |
Funds withheld at interest – embedded derivative | — |  |  | (3,958) |  |  | — |  |  | — |  |  | — |  |  | (3,958) |  |  | — |  |  | — |
Short-term investments | 29 |  |  | — |  |  | (1) |  |  | 30 |  |  | — |  |  | 58 |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 670 |  |  | (4) |  |  | (6) |  |  | 136 |  |  | 53 |  |  | 849 |  |  | — |  |  | (6) |
CLO | 202 |  |  | — |  |  | (7) |  |  | 130 |  |  | — |  |  | 325 |  |  | — |  |  | (7) |
ABS | 6,445 |  |  | (1) |  |  | (135) |  |  | (1,241) |  |  | (42) |  |  | 5,026 |  |  | — |  |  | (138) |
Trading securities | 1,771 |  |  | (1) |  |  | — |  |  | (1,062) |  |  | 183 |  |  | 891 |  |  | — |  |  | — |
Equity securities | 284 |  |  | (14) |  |  | — |  |  | (119) |  |  | 12 |  |  | 163 |  |  | — |  |  | — |
Mortgage loans | 1,369 |  |  | (124) |  |  | — |  |  | 171 |  |  | — |  |  | 1,416 |  |  | (124) |  |  | — |
Investment funds | 2,855 |  |  | 28 |  |  | — |  |  | (34) |  |  | (2,031) |  |  | 818 |  |  | 28 |  |  | — |
Funds withheld at interest – embedded derivative | — |  |  | (1,129) |  |  | — |  |  | — |  |  | — |  |  | (1,129) |  |  | — |  |  | — |
Short-term investments | — |  |  | — |  |  | — |  |  | 53 |  |  | (53) |  |  | — |  |  | — |  |  | — |
Reinsurance recoverable | 1,991 |  |  | (411) |  |  | — |  |  | — |  |  | — |  |  | 1,580 |  |  | — |  |  | — |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | — |  |  | — |  |  | — |  |  | — |  |  | 330 |  |  | 330 |  |  | — |  |  | — |
Mortgage loans | 2,152 |  |  | (170) |  |  | — |  |  | (154) |  |  | (202) |  |  | 1,626 |  |  | (170) |  |  | — |
Investment funds | 1,297 |  |  | 28 |  |  | — |  |  | 161 |  |  | (433) |  |  | 1,053 |  |  | 28 |  |  | — |
Other investments | — |  |  | — |  |  | — |  |  | 31 |  |  | — |  |  | 31 |  |  | — |  |  | — |
Total Level 3 assets | $ | 45,752 |  |  | $ | (7,513) |  |  | $ | (338) |  |  | $ | 4,178 |  |  | $ | (2,391) |  |  | $ | 39,688 |  |  | $ | (1,988) |  |  | $ | (315) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Embedded derivative | $ | (7,408) |  |  | $ | 2,553 |  |  | $ | — |  |  | $ | (321) |  |  | $ | — |  |  | $ | (5,176) |  |  | $ | — |  |  | $ | — |
Universal life benefits | (1,235) |  |  | 292 |  |  | — |  |  | — |  |  | — |  |  | (943) |  |  | — |  |  | — |
Future policy benefits |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AmerUs Closed Block | (1,520) |  |  | 273 |  |  | — |  |  | — |  |  | — |  |  | (1,247) |  |  | — |  |  | — |
ILICO Closed Block and life benefits | (742) |  |  | 119 |  |  | — |  |  | — |  |  | — |  |  | (623) |  |  | — |  |  | — |
Derivative liabilities | (3) |  |  | 2 |  |  | — |  |  | — |  |  | — |  |  | (1) |  |  | — |  |  | — |
Total Level 3 liabilities | $ | (10,908) |  |  | $ | 3,239 |  |  | $ | — |  |  | $ | (321) |  |  | $ | — |  |  | $ | (7,990) |  |  | $ | — |  |  | $ | — |
1 Related to instruments held at end of period. |  |
Gross Components of Purchases, Sales, Issuances and Settlements, net | The following represents the gross components of purchases, issuances, sales and settlements, net, and net transfers in (out) shown above:
| Three months ended June 30, 2023
(In millions) | Purchases |  | Issuances |  | Sales |  | Settlements |  | Net purchases, issuances, sales and settlements |  | Transfers in |  | Transfers out |  | Net transfers in (out)
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign governments | $ | 53 |  |  | $ | — |  |  | $ | — |  |  | $ | (6) |  |  | $ | 47 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Corporate | 1,104 |  |  | — |  |  | — |  |  | (34) |  |  | 1,070 |  |  | — |  |  | (244) |  |  | (244) |
ABS | 1,033 |  |  | — |  |  | (20) |  |  | (119) |  |  | 894 |  |  | 123 |  |  | (623) |  |  | (500) |
CMBS | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 12 |  |  | — |  |  | 12 |
RMBS | — |  |  | — |  |  | — |  |  | (3) |  |  | (3) |  |  | 5 |  |  | (236) |  |  | (231) |
Trading securities | 8 |  |  | — |  |  | — |  |  | (11) |  |  | (3) |  |  | — |  |  | (2) |  |  | (2) |
Mortgage loans | 5,783 |  |  | — |  |  | (31) |  |  | (838) |  |  | 4,914 |  |  | — |  |  | — |  |  | — |
Other investments | 325 |  |  | — |  |  | — |  |  | (273) |  |  | 52 |  |  | — |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 1 |  |  | — |  |  | — |  |  | (3) |  |  | (2) |  |  | 215 |  |  | — |  |  | 215 |
ABS | 1,072 |  |  | — |  |  | (162) |  |  | (467) |  |  | 443 |  |  | 284 |  |  | — |  |  | 284 |
Trading securities | 25 |  |  | — |  |  | (37) |  |  | (2) |  |  | (14) |  |  | — |  |  | — |  |  | — |
Mortgage loans | — |  |  | — |  |  | — |  |  | (19) |  |  | (19) |  |  | — |  |  | — |  |  | — |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | 10 |  |  | — |  |  | (18) |  |  | — |  |  | (8) |  |  | 817 |  |  | (28) |  |  | 789 |
Mortgage loans | 13 |  |  | — |  |  | — |  |  | (2) |  |  | 11 |  |  | — |  |  | — |  |  | — |
Investment funds | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 327 |  |  | (1,562) |  |  | (1,235) |
Total Level 3 assets | $ | 9,427 |  |  | $ | — |  |  | $ | (268) |  |  | $ | (1,777) |  |  | $ | 7,382 |  |  | $ | 1,783 |  |  | $ | (2,695) |  |  | $ | (912) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities – embedded derivative | $ | — |  |  | $ | (558) |  |  | $ | — |  |  | $ | 162 |  |  | $ | (396) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total Level 3 liabilities | $ | — |  |  | $ | (558) |  |  | $ | — |  |  | $ | 162 |  |  | $ | (396) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
| Three months ended June 30, 2022
(In millions) | Purchases |  | Issuances |  | Sales |  | Settlements |  | Net purchases, issuances, sales and settlements |  | Transfers in 1 |  | Transfers out 2 |  | Net transfers in (out)
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | $ | 129 |  |  | $ | — |  |  | $ | (2) |  |  | $ | (87) |  |  | $ | 40 |  |  | $ | 150 |  |  | $ | (43) |  |  | $ | 107 |
CLO | — |  |  | — |  |  | — |  |  | (2) |  |  | (2) |  |  | — |  |  | — |  |  | — |
ABS | 746 |  |  | — |  |  | (341) |  |  | (257) |  |  | 148 |  |  | 30 |  |  | (304) |  |  | (274) |
CMBS | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (10) |  |  | (10) |
RMBS | 68 |  |  | — |  |  | — |  |  | — |  |  | 68 |  |  | — |  |  | — |  |  | — |
Trading securities | 2 |  |  | — |  |  | — |  |  | — |  |  | 2 |  |  | 9 |  |  | (42) |  |  | (33) |
Equity securities | — |  |  | — |  |  | (3) |  |  | — |  |  | (3) |  |  | 19 |  |  | (400) |  |  | (381) |
Mortgage loans | 3,386 |  |  | — |  |  | (48) |  |  | (789) |  |  | 2,549 |  |  | — |  |  | — |  |  | — |
Short-term investments | 29 |  |  | — |  |  | — |  |  | (29) |  |  | — |  |  | — |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 52 |  |  | — |  |  | — |  |  | (10) |  |  | 42 |  |  | 53 |  |  | — |  |  | 53 |
ABS | 899 |  |  | — |  |  | (6) |  |  | (1,989) |  |  | (1,096) |  |  | 1,822 |  |  | — |  |  | 1,822 |
Trading securities | 7 |  |  | — |  |  | (787) |  |  | (28) |  |  | (808) |  |  | 1,443 |  |  | — |  |  | 1,443 |
Equity securities | — |  |  | — |  |  | (119) |  |  | — |  |  | (119) |  |  | 125 |  |  | — |  |  | 125 |
Mortgage loans | 36 |  |  | — |  |  | — |  |  | (4) |  |  | 32 |  |  | — |  |  | — |  |  | — |
Short-term investments | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (53) |  |  | (53) |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 330 |  |  | — |  |  | 330 |
Mortgage loans | — |  |  | — |  |  | — |  |  | (2) |  |  | (2) |  |  | 21 |  |  | (223) |  |  | (202) |
Investment funds | 33 |  |  | — |  |  | (110) |  |  | — |  |  | (77) |  |  | 1,006 |  |  | (10,486) |  |  | (9,480) |
Other investments | 31 |  |  | — |  |  | — |  |  | — |  |  | 31 |  |  | — |  |  | (1,902) |  |  | (1,902) |
Total Level 3 assets | $ | 5,418 |  |  | $ | — |  |  | $ | (1,416) |  |  | $ | (3,197) |  |  | $ | 805 |  |  | $ | 5,008 |  |  | $ | (13,463) |  |  | $ | (8,455) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities – embedded derivative | $ | — |  |  | $ | (337) |  |  | $ | — |  |  | $ | 127 |  |  | $ | (210) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total Level 3 liabilities | $ | — |  |  | $ | (337) |  |  | $ | — |  |  | $ | 127 |  |  | $ | (210) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
1 Transfers in are primarily assets of VIEs that we consolidated effective in the second quarter of 2022.
2 Transfers out are primarily the deconsolidation of certain of our VIEs effective in the second quarter of 2022.
| Six months ended June 30, 2023
(In millions) | Purchases |  | Issuances |  | Sales |  | Settlements |  | Net purchases, issuances, sales and settlements |  | Transfers in |  | Transfers out |  | Net transfers in (out)
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign governments | $ | 53 |  |  | $ | — |  |  | $ | — |  |  | $ | (6) |  |  | $ | 47 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Corporate | 1,312 |  |  | — |  |  | — |  |  | (116) |  |  | 1,196 |  |  | 29 |  |  | (453) |  |  | (424) |
ABS | 1,331 |  |  | — |  |  | (20) |  |  | (262) |  |  | 1,049 |  |  | 338 |  |  | (899) |  |  | (561) |
CMBS | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 12 |  |  | — |  |  | 12 |
RMBS | 1 |  |  | — |  |  | — |  |  | (4) |  |  | (3) |  |  | 5 |  |  | (236) |  |  | (231) |
Trading securities | 8 |  |  | — |  |  | — |  |  | (15) |  |  | (7) |  |  | 5 |  |  | (16) |  |  | (11) |
Equity securities | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (13) |  |  | (13) |
Mortgage loans | 8,665 |  |  | — |  |  | (63) |  |  | (1,444) |  |  | 7,158 |  |  | — |  |  | — |  |  | — |
Short-term investments | — |  |  | — |  |  | — |  |  | (30) |  |  | (30) |  |  | 26 |  |  | — |  |  | 26 |
Other investments | 327 |  |  | — |  |  | — |  |  | (431) |  |  | (104) |  |  | — |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 157 |  |  | — |  |  | — |  |  | (6) |  |  | 151 |  |  | 215 |  |  | — |  |  | 215 |
CLO | 185 |  |  | — |  |  | — |  |  | — |  |  | 185 |  |  | — |  |  | — |  |  | — |
ABS | 2,706 |  |  | — |  |  | (162) |  |  | (686) |  |  | 1,858 |  |  | 284 |  |  | — |  |  | 284 |
Trading securities | 27 |  |  | — |  |  | (37) |  |  | (3) |  |  | (13) |  |  | — |  |  | — |  |  | — |
Equity securities | — |  |  | — |  |  | — |  |  | (32) |  |  | (32) |  |  | — |  |  | — |  |  | — |
Mortgage loans | — |  |  | — |  |  | — |  |  | (23) |  |  | (23) |  |  | — |  |  | — |  |  | — |
Investment funds | 32 |  |  | — |  |  | — |  |  | — |  |  | 32 |  |  | — |  |  | — |  |  | — |
Other investments | 42 |  |  | — |  |  | — |  |  | — |  |  | 42 |  |  | — |  |  | — |  |  | — |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | 20 |  |  | — |  |  | (30) |  |  | — |  |  | (10) |  |  | 836 |  |  | (31) |  |  | 805 |
Mortgage loans | 59 |  |  | — |  |  | — |  |  | (3) |  |  | 56 |  |  | — |  |  | — |  |  | — |
Investment funds | — |  |  | — |  |  | (8) |  |  | — |  |  | (8) |  |  | 475 |  |  | (1,610) |  |  | (1,135) |
Other investments | 5 |  |  | — |  |  | (7) |  |  | — |  |  | (2) |  |  | — |  |  | — |  |  | — |
Total Level 3 assets | $ | 14,930 |  |  | $ | — |  |  | $ | (327) |  |  | $ | (3,061) |  |  | $ | 11,542 |  |  | $ | 2,225 |  |  | $ | (3,258) |  |  | $ | (1,033) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities – embedded derivative | $ | — |  |  | $ | (1,135) |  |  | $ | — |  |  | $ | 306 |  |  | $ | (829) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total Level 3 liabilities | $ | — |  |  | $ | (1,135) |  |  | $ | — |  |  | $ | 306 |  |  | $ | (829) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
| Six months ended June 30, 2022
(In millions) | Purchases |  | Issuances |  | Sales |  | Settlements |  | Net purchases, issuances, sales and settlements |  | Transfers in 1 |  | Transfers out 2 |  | Net transfers in (out)
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | $ | 453 |  |  | $ | — |  |  | $ | (170) |  |  | $ | (103) |  |  | $ | 180 |  |  | $ | 193 |  |  | $ | (44) |  |  | $ | 149 |
CLO | — |  |  | — |  |  | — |  |  | (12) |  |  | (12) |  |  | — |  |  | — |  |  | — |
ABS | 2,235 |  |  | — |  |  | (1,791) |  |  | (444) |  |  | — |  |  | 368 |  |  | (305) |  |  | 63 |
CMBS | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (26) |  |  | (26) |
RMBS | 68 |  |  | — |  |  | — |  |  | — |  |  | 68 |  |  | — |  |  | — |  |  | — |
Trading securities | 8 |  |  | — |  |  | — |  |  | — |  |  | 8 |  |  | 39 |  |  | (52) |  |  | (13) |
Equity securities | — |  |  | — |  |  | (3) |  |  | — |  |  | (3) |  |  | 19 |  |  | (400) |  |  | (381) |
Mortgage loans | 7,477 |  |  | — |  |  | (130) |  |  | (1,512) |  |  | 5,835 |  |  | — |  |  | — |  |  | — |
Short-term investments | 59 |  |  | — |  |  | — |  |  | (29) |  |  | 30 |  |  | — |  |  | — |  |  | — |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
AFS securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Corporate | 367 |  |  | — |  |  | (217) |  |  | (14) |  |  | 136 |  |  | 53 |  |  | — |  |  | 53 |
CLO | 130 |  |  | — |  |  | — |  |  | — |  |  | 130 |  |  | — |  |  | — |  |  | — |
ABS | 1,273 |  |  | — |  |  | (93) |  |  | (2,421) |  |  | (1,241) |  |  | 1,822 |  |  | (1,864) |  |  | (42) |
Trading securities | 36 |  |  | — |  |  | (1,052) |  |  | (46) |  |  | (1,062) |  |  | 1,443 |  |  | (1,260) |  |  | 183 |
Equity securities | — |  |  | — |  |  | (119) |  |  | — |  |  | (119) |  |  | 125 |  |  | (113) |  |  | 12 |
Mortgage securities | 182 |  |  | — |  |  | — |  |  | (11) |  |  | 171 |  |  | — |  |  | — |  |  | — |
Investment funds | — |  |  | — |  |  | (34) |  |  | — |  |  | (34) |  |  | — |  |  | (2,031) |  |  | (2,031) |
Short-term investments | 53 |  |  | — |  |  | — |  |  | — |  |  | 53 |  |  | — |  |  | (53) |  |  | (53) |
Assets of consolidated VIEs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trading securities | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 330 |  |  | — |  |  | 330 |
Mortgage loans | — |  |  | — |  |  | — |  |  | (154) |  |  | (154) |  |  | 21 |  |  | (223) |  |  | (202) |
Investment funds | 286 |  |  | — |  |  | (125) |  |  | — |  |  | 161 |  |  | 11,087 |  |  | (11,520) |  |  | (433) |
Other investments | 31 |  |  | — |  |  | — |  |  | — |  |  | 31 |  |  | 1,902 |  |  | (1,902) |  |  | — |
Total Level 3 assets | $ | 12,658 |  |  | $ | — |  |  | $ | (3,734) |  |  | $ | (4,746) |  |  | $ | 4,178 |  |  | $ | 17,402 |  |  | $ | (19,793) |  |  | $ | (2,391) |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities – embedded derivative | $ | — |  |  | $ | (597) |  |  | $ | — |  |  | $ | 276 |  |  | $ | (321) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Total Level 3 liabilities | $ | — |  |  | $ | (597) |  |  | $ | — |  |  | $ | 276 |  |  | $ | (321) |  |  | $ | — |  |  | $ | — |  |  | $ | — |
1 Transfers in are primarily assets of VIEs that we consolidated in 2022.
2 Transfers out are primarily assets of VIEs that changed consolidation status in 2022.
Summary of the Unobservable Inputs for the Embedded Derivative of Fixed Indexed Annuities | The following summarizes the unobservable inputs for AFS, trading and equity securities, mortgage loans, investment funds and the embedded derivatives of fixed indexed annuities, including those of consolidated VIEs:
|  | June 30, 2023
(In millions, except for percentages and multiples) |  | Fair value |  | Valuation technique |  | Unobservable inputs |  | Minimum |  | Maximum |  | Weighted average |  | Impact of an increase in the input on fair value
AFS, trading and equity securities |  | $ | 13,800 |  |  | Discounted cash flow |  | Discount rate |  | 2.2 | % |  | 18.7 | % |  | 6.9 | % | 1 |  | Decrease
Mortgage loans |  | 38,077 |  |  | Discounted cash flow |  | Discount rate |  | 2.0 | % |  | 24.2 | % |  | 6.5 | % | 1 |  | Decrease
Investment funds |  | 502 |  |  | Discounted cash flow |  | Discount rate |  | 6.4 | % |  | 6.4 | % |  | 6.4 | % |  |  | Decrease
|  | 512 |  |  | Net tangible asset values |  | Implied multiple |  | 1.20x |  | 1.20x |  | 1.20x |  |  | Increase
|  | 337 |  |  | Reported net asset value |  | Reported net asset value |  | N/A |  | N/A |  | N/A |  |  | N/A
Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives |  | 8,198 |  |  | Discounted cash flow |  | Nonperformance risk |  | 0.4 | % |  | 1.8 | % |  | 1.2 | % | 2 |  | Decrease
|  |  |  |  |  | Option budget |  | 0.5 | % |  | 5.7 | % |  | 2.2 | % | 3 |  | Increase
|  |  |  |  |  | Surrender rate |  | 5.4 | % |  | 12.0 | % |  | 8.1 | % | 3 |  | Decrease
|  | December 31, 2022
(In millions, except for percentages and multiples) |  | Fair value |  | Valuation technique |  | Unobservable inputs |  | Minimum |  | Maximum |  | Weighted average |  | Impact of an increase in the input on fair value
AFS, trading and equity securities |  | $ | 10,671 |  |  | Discounted cash flow |  | Discount rate |  | 2.2 | % |  | 18.8 | % |  | 6.8 | % | 1 |  | Decrease
Mortgage loans |  | 30,811 |  |  | Discounted cash flow |  | Discount rate |  | 1.5 | % |  | 22.1 | % |  | 6.3 | % | 1 |  | Decrease
Investment funds |  | 506 |  |  | Discounted cash flow |  | Discount rate |  | 6.4 | % |  | 6.4 | % |  | 6.4 | % |  |  | Decrease
|  | 873 |  |  | Discounted cash flow / Guideline public equity |  | Discount rate / P/E |  | 16.5% / 9x |  | 16.5% / 9x |  | 16.5% / 9x |  |  | Decrease/Increase
|  | 529 |  |  | Net tangible asset values |  | Implied multiple |  | 1.26x |  | 1.26x |  | 1.26x |  |  | Increase
|  | 563 |  |  | Reported net asset value |  | Reported net asset value |  | N/A |  | N/A |  | N/A |  |  | N/A
Interest sensitive contract liabilities – fixed indexed annuities embedded derivatives |  | 5,841 |  |  | Discounted cash flow |  | Nonperformance risk |  | 0.1 | % |  | 1.7 | % |  | 1.0 | % | 2 |  | Decrease
|  |  |  |  |  | Option budget |  | 0.5 | % |  | 5.3 | % |  | 1.9 | % | 3 |  | Increase
|  |  |  |  |  | Surrender rate |  | 5.1 | % |  | 11.5 | % |  | 8.1 | % | 3 |  | Decrease
1 The discount rate weighted average is calculated based on the relative fair values of the securities or loans.
2 The nonperformance risk weighted average is based on the projected cash flows attributable to the embedded derivative.
3 The option budget and surrender rate weighted averages are calculated based on projected account values.
The following summarizes the unobservable inputs for market risk benefits:
|  | June 30, 2023
(In millions, except for percentages) |  | Fair value |  | Valuation technique |  | Unobservable inputs |  | Minimum |  | Maximum |  | Weighted average |  | Impact of an increase in the input on fair value
Market risk benefits, net |  | $ | 2,762 |  |  | Discounted cash flow |  | Nonperformance risk |  | 0.4 | % |  | 1.8 | % |  | 1.5 | % | 1 |  | Decrease
|  |  |  |  |  | Option budget |  | 0.5 | % |  | 5.7 | % |  | 1.8 | % | 2 |  | Decrease
|  |  |  |  |  | Surrender rate |  | 3.3 | % |  | 6.9 | % |  | 4.5 | % | 2 |  | Decrease
|  |  |  |  |  | Utilization rate |  | 28.6 | % |  | 95.0 | % |  | 83.1 | % | 3 |  | Increase
|  | June 30, 2022
(In millions, except for percentages) |  | Fair value |  | Valuation technique |  | Unobservable inputs |  | Minimum |  | Maximum |  | Weighted average |  | Impact of an increase in the input on fair value
Market risk benefits, net |  | $ | 2,674 |  |  | Discounted cash flow |  | Nonperformance risk |  | 0.5 | % |  | 2.0 | % |  | 1.6 | % | 1 |  | Decrease
|  |  |  |  |  | Option budget |  | 0.5 | % |  | 4.0 | % |  | 1.6 | % | 2 |  | Decrease
|  |  |  |  |  | Surrender rate |  | 3.3 | % |  | 6.8 | % |  | 4.5 | % | 2 |  | Decrease
|  |  |  |  |  | Utilization rate |  | 28.6 | % |  | 95.0 | % |  | 81.6 | % | 3 |  | Increase
1 The nonperformance risk weighted average is based on the cash flows underlying the market risk benefit reserve.
2 The option budget and surrender rate weighted averages are calculated based on projected account values.
3 The utilization of GLWB withdrawals represents the estimated percentage of policyholders that are expected to use their income rider over the duration of the contract, with the weighted average based on current account values.
Summary of Financial Instruments Not Carried at Fair Value on the Balance Sheet | The following represents our financial instruments not carried at fair value on the condensed consolidated balance sheets:
| June 30, 2023
(In millions) | Carrying Value |  | Fair Value |  | NAV |  | Level 1 |  | Level 2 |  | Level 3
Financial assets |  |  |  |  |  |  |  |  |  |  |
Investment funds | $ | 123 |  |  | $ | 123 |  |  | $ | 123 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Policy loans | 336 |  |  | 336 |  |  | — |  |  | — |  |  | 336 |  |  | — |
Funds withheld at interest | 32,200 |  |  | 32,200 |  |  | — |  |  | — |  |  | — |  |  | 32,200 |
Other investments | 194 |  |  | 195 |  |  | — |  |  | — |  |  | — |  |  | 195 |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |
Investment funds | 575 |  |  | 575 |  |  | 575 |  |  | — |  |  | — |  |  | — |
Funds withheld at interest | 10,314 |  |  | 10,314 |  |  | — |  |  | — |  |  | — |  |  | 10,314 |
Short-term investments | 891 |  |  | 891 |  |  | — |  |  | — |  |  | 891 |  |  | — |
Total financial assets not carried at fair value | $ | 44,633 |  |  | $ | 44,634 |  |  | $ | 698 |  |  | $ | — |  |  | $ | 1,227 |  |  | $ | 42,709 |
Financial liabilities |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities | $ | 134,154 |  |  | $ | 121,326 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 121,326 |
Debt | 3,642 |  |  | 2,873 |  |  | — |  |  | — |  |  | 2,873 |  |  | — |
Securities to repurchase | 6,261 |  |  | 6,261 |  |  | — |  |  | — |  |  | 6,261 |  |  | — |
Funds withheld liability | 305 |  |  | 305 |  |  | — |  |  | — |  |  | 305 |  |  | — |
Total financial liabilities not carried at fair value | $ | 144,362 |  |  | $ | 130,765 |  |  | $ | — |  |  | $ | — |  |  | $ | 9,439 |  |  | $ | 121,326 |
| December 31, 2022
(In millions) | Carrying Value |  | Fair Value |  | NAV |  | Level 1 |  | Level 2 |  | Level 3
Financial assets |  |  |  |  |  |  |  |  |  |  |
Investment funds | $ | 79 |  |  | $ | 79 |  |  | $ | 79 |  |  | $ | — |  |  | $ | — |  |  | $ | — |
Policy loans | 347 |  |  | 347 |  |  | — |  |  | — |  |  | 347 |  |  | — |
Funds withheld at interest | 37,727 |  |  | 37,727 |  |  | — |  |  | — |  |  | — |  |  | 37,727 |
Short-term investments | 1,640 |  |  | 1,640 |  |  | — |  |  | — |  |  | 1,614 |  |  | 26 |
Other investments | 162 |  |  | 162 |  |  | — |  |  | — |  |  | — |  |  | 162 |
Investments in related parties |  |  |  |  |  |  |  |  |  |  |
Investment funds | 610 |  |  | 610 |  |  | 610 |  |  | — |  |  | — |  |  | — |
Funds withheld at interest | 11,233 |  |  | 11,233 |  |  | — |  |  | — |  |  | — |  |  | 11,233 |
Total financial assets not carried at fair value | $ | 51,798 |  |  | $ | 51,798 |  |  | $ | 689 |  |  | $ | — |  |  | $ | 1,961 |  |  | $ | 49,148 |
Financial liabilities |  |  |  |  |  |  |  |  |  |  |
Interest sensitive contract liabilities | $ | 125,101 |  |  | $ | 111,608 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 111,608 |
Debt | 3,658 |  |  | 2,893 |  |  | — |  |  | — |  |  | 2,893 |  |  | — |
Securities to repurchase | 4,743 |  |  | 4,743 |  |  | — |  |  | — |  |  | 4,743 |  |  | — |
Funds withheld liability | 360 |  |  | 360 |  |  | — |  |  | — |  |  | 360 |  |  | — |
Total financial liabilities not carried at fair value | $ | 133,862 |  |  | $ | 119,604 |  |  | $ | — |  |  | $ | — |  |  | $ | 7,996 |  |  | $ | 111,608 |

X
- Definition Level 3 Purchases Sales Issuances Settlements [Table Text Block] + References No definition available. + Details
Name: | ahl_Level3PurchasesSalesIssuancesSettlementsTableTextBlock
Namespace Prefix: | ahl_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -SubTopic 10 -Topic 820 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11 + Details
Name: | us-gaap_FairValueByBalanceSheetGroupingTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information about asset and liability measured at fair value under fair value option. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-30 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-31 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-32 + Details
Name: | us-gaap_FairValueOptionQuantitativeDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration